...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >A Xanthine-Based Epithelium-Dependent Airway Relaxant KMUP-3 (7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) Increases Respiratory Performance and Protects against Tumor Necrosis Factor-alpha-lnduced Tracheal Contraction,Involving N
【24h】

A Xanthine-Based Epithelium-Dependent Airway Relaxant KMUP-3 (7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) Increases Respiratory Performance and Protects against Tumor Necrosis Factor-alpha-lnduced Tracheal Contraction,Involving N

机译:黄嘌呤为基础的上皮依赖性气道松弛剂KMUP-3(7- [2- [4-(4-(硝基苯)哌嗪基]乙基] -1,3-二甲基黄嘌呤)增加呼吸性能,并防止肿瘤坏死因子-α诱导。气管收缩,累及N

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethyl-xanthine) was investigated in guinea pig tracheal smooth muscle.Intratracheal instillation of tumor necrosis factor (TNF)-alpha (0.01 mg/kg/300 mu l) induced bronchoconstriction,increases of lung resistance,and decreases of dynamic lung compliance.Instillation of KMUP-3 (0.5-2.0 mg/kg) reversed this situation.In isolated trachea precontracted with carbachol,KMUP-3 (10-100 mu M)-caused relaxations were attenuated by epithelium removal and by pretreatments with an inhibitor of K~+ channel,tetraethylammo-nium (10 mM); K_(ATP) channel,glibenclamide (1 mu M); voltage-dependent K~+ channel,4-aminopyridine (100 mu M); Ca~(2+)-dependent K~+ channel,charybdotoxin (0.1 mu M) or apamin (1 mu M); soluble guanylate cyclase (sGC),1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ,1 mu M); nitric-oxide (NO) synthase,N~(omega)-nitro-L-arginine methyl ester (L-NAME,100 mu M); and adenylate cyclase,SQ 22536 [9-(terahydro-2-furanyl)-9H-purin-6-amine] (100 mu M).KMUP-3 (0.01-100 mu M) induced increases of cGMP and cAMP in primary culture of tracheal smooth muscle cells (TSMCs).The increase in cGMP by KMUP-3 was reduced by ODQ and L-NAME; the increase in cAMP was reduced by SQ 22536.Western blot analysis indicated that KMUP-3 (1 mu M) induced expression of protein kinase A (PKA)_(RI) and protein kinase G (PKG)_(1alpha1beta) in TSMCs.SQ 22536 inhibited KMUP-3-induced expression of PKA_(RI).On the contrary,ODQ inhibited KMUP-3-induced expression of PKG_(1alpha1beta).In epithelium-intact trachea,KMUP-3 increased the NO release.Activation of sGC,NO release,and inhibition of phosphodiester-ases in TSMCs by KMUP-3 may result in increases of intracellular cGMP and cAMP,which subsequently activate PKG and PKA,efflux of K~+ ion,and associated reduction in Ca~(2+) influx in vitro,indicating the action mechanism to protect against TNF-alpha-in-duced airway dysfunction in vivo.
机译:在豚鼠气管平滑肌中研究了KMUP-3(7- [2- [4-(4-硝基苯)哌嗪基]乙基] -1,3-二甲基黄嘌呤)。气管内滴注肿瘤坏死因子(TNF)-α (0.01 mg / kg / 300μl)引起支气管狭窄,肺阻力增加和动态肺顺应性降低。滴注KMUP-3(0.5-2.0 mg / kg)可以逆转这种情况。通过上皮去除和用K〜+通道抑制剂四乙铵(10 mM)预处理减弱了-3(10-100μM)引起的弛豫。 K_(ATP)通道,格列本脲(1μM);电压依赖性钾离子通道,4-氨基吡啶(100μM); Ca〜(2+)依赖性K〜+通道,软骨毒素(0.1μM)或阿帕明(1μM);可溶性鸟苷酸环化酶(sGC),1H- [1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ,1μM);一氧化氮(NO)合酶,N〜(ω)-硝基-L-精氨酸甲酯(L-NAME,100μM);和腺苷酸环化酶,SQ 22536 [9-(四氢-2-呋喃基)-9H-嘌呤-6-胺](100μM)。KMUP-3(0.01-100μM)诱导原代培养物中cGMP和cAMP的增加ODQ和L-NAME降低了KMUP-3对cGMP的增加。 SQ 22536降低了cAMP的增加。Westernblot分析表明,KMUP-3(1μM)诱导了TSMCs中蛋白激酶A(PKA)_(RI)和蛋白激酶G(PKG)_(1alpha1beta)的表达。 SQ 22536抑制KMUP-3诱导的PKA_(RI)表达,相反,ODQ抑制KMUP-3诱导的PKG_(1alpha1beta)表达。在上皮完整的气管中,KMUP-3增加NO的释放。 ,NO释放以及KMUP-3抑制TSMC中的磷酸二酯酶可能导致细胞内cGMP和cAMP升高,继而激活PKG和PKA,K〜+离子流出以及相关的Ca〜(2+)降低体外涌入,表明体内保护机制可抵抗TNF-α诱导的气道功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号